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Abstract. 
 
MDCK cells expressing RhoA or Rac1 mu-
tants under control of the tetracycline repressible trans-
activator were used to examine short-term effects of 
known amounts of each mutant before, during, or after 
development of cell polarity. At low cell density, 
Rac1V12 cells had a flattened morphology and intact 
cell–cell contacts, whereas Rac1N17 cells were tightly 
compacted. Abnormal intracellular aggregates formed 
between Rac1N17, F-actin, and E-cadherin in these 
nonpolarized cells. At all subsequent stages of polarity 
development, Rac1N17 and Rac1V12 colocalized with 
E-cadherin and F-actin in an unusual beaded pattern at 
lateral membranes. In polarized cells, intracellular ag-
gregates formed with Rac1V12, F-actin, and an apical 
membrane protein (GP135). At low cell density, 
RhoAV14 and RhoAN19 were localized in the cyto-
plasm, and cells were generally flattened and more fi-
broblastic than epithelial in morphology. In polarized 
RhoAV14 cells, F-actin was diffuse at lateral mem-
branes and prominent in stress fibers on the basal mem-
brane. GP135 was abnormally localized to the lateral 
membrane and in intracellular aggregates, but E-cad-
herin distribution appeared normal. In RhoAN19 cells, 
F-actin, E-cadherin, and GP135 distributions were simi-
lar to those in controls. Expression of either RhoAV14 
or RhoAN19 in Rac1V12 cells disrupted Rac1V12 dis-
tribution and caused cells to adopt the more fibroblas-
tic, RhoA mutant phenotype. We suggest that Rac1 
and RhoA are involved in the transition of epithelial 
cells from a fibroblastic to a polarized structure and 
function by direct and indirect regulation of actin and 
actin-associated membrane protein organizations.
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 RhoA family of proteins, consisting of RhoA,
Rac1, and Cdc42 subfamilies, are relatives of the
small GTP-binding protein Ras (Hall, 1998). Like
Ras, RhoA GTPases cycle between an active GTP-bound
state and an inactive GDP-bound state (Bourne, 1993;
Hall, 1998). Transitions between GTP- and GDP-bound
forms of small GTPases are controlled by specialized regu-
lators (Bourne, 1993). By cycling between GTP- and
GDP-bound states, RhoA family GTPases transduce sig-
nals from cell surface receptors to intracellular target mol-
ecules (Hall, 1998).
Microinjection of dominant-active or dominant-nega-
tive RhoA GTPases revealed that each subfamily regu-
lates, in a hierarchical manner, the formation and organi-
zation of specialized actin membrane structures in Swiss
3T3 fibroblasts (Hall, 1998). Cdc42 regulates filopodia for-
mation, Rac1 controls lamellipodia and membrane ruf-
fling, and RhoA is involved in the assembly and organiza-
tion of stress fibers and focal adhesions (Ridley and Hall,
1992; Ridley et al., 1992; Nobes and Hall, 1995; Hall,
1998). These initial studies in fibroblasts have been ex-
tended to show that RhoA GTPases are involved in many
other biological processes, including cell shape, cell motil-
ity, endocytosis, exocytosis, cell–substratum adhesion, and
cytokinesis, all of which may involve RhoA GTPase con-
trol of actin-based structures (Symons, 1996; Burridge et al.,
1997; Hall, 1998).
How RhoA GTPases regulate actin membrane struc-
tures is not well understood. Several downstream effectors
of RhoA have been identified, including Rho-activated
serine/threonine kinases (termed Rho-kinase, ROK
 
a
 
 and
ROK
 
b
 
, and p160ROCK; Leung et al., 1995, 1996; Ishizaki
et al., 1996; Matsui et al., 1996), which have pointed to a
role of RhoA GTPases in regulating actinomyosin–based
contractility. Rho-kinases phosphorylate both the regula-
tory subunit of the myosin phosphatase and the regulatory
myosin light chain (Amano et al., 1996; Kimura et al.,
1996). These activities cause an increase in myosin light
chain phosphorylation and, thereby, promote a conforma-
tional change in myosin II that leads to bipolar filament
formation and stimulate myosin ATPase activity (Burr-
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idge and Chrzanowska, 1996). Conformational changes in
myosin II and myosin ATPase activity are required for
the interaction of myosin with actin filaments and subse-
quent force generation. Another downstream effector of
RhoA GTPases may be phosphatidylinositol 4-phosphate
5-kinase (Chong et al., 1994), which regulates phosphati-
dylinositol (4,5)-bisphosphate (PIP
 
2
 
)
 
1
 
 synthesis. PIP
 
2
 
 has
broad effects on the actin cytoskeleton, including binding
to actin-monomer binding proteins (e.g., profilin), which
results in release of actin monomers (Lassing and Lind-
berg, 1985; Goldschmidt et al., 1990), and causing the dis-
sociation of capping proteins (e.g., gelsolin) from the ends
of actin filaments (Fukami et al., 1992). Recently, the
ezrin-radixin-moesin (ERM) family of actin-associated
proteins (Matsui et al., 1998) and adducin (Kimura et al.,
1998) have also been shown to be substrates for Rho-
kinase. In general, all of these activities are likely to lead
to promotion of actin filament assembly (Burridge et al.,
1997).
These studies have provided important insights into the
functions of RhoA GTPases in single, motile cells, but lit-
tle is known about the role of RhoA GTPases in the struc-
tural and functional organization of epithelial cells, which
interact to form organs and tissues. Studies in 
 
Drosophila
 
indicate that Rac1 and Cdc42 regulate several aspects of
epithelial cell organization in the imaginal disc, including
cell survival, apico–basal epithelial elongation, and actin
organization at cell–cell contacts and at the base of cells
(Eaton et al., 1995). Other studies have focused on roles of
RhoA GTPases in epithelial cells in vitro. In one study, it
was reported that microinjection of RhoA or Rac1 mu-
tants into keratinocytes disrupted E-cadherin–dependent
cell–cell adhesion (Braga et al., 1997). Another study
showed that expression of C3 exoenzyme, which ADP ri-
bosylates and inactivates RhoA, disrupted tight junction
organization and function in T84 intestinal epithelial cells,
but did not affect cell–cell interactions (Nusrat et al.,
1995). In contrast to those studies, it was reported recently
that RhoA or Rac1 mutants had little or no effect on ei-
ther cell–cell adhesion or tight junction organization in
MDCK cells, except during PKC-induced TJ assembly in
the presence of low extracellular calcium concentrations
(Takaishi et al., 1997). The reason for the differences in
these results and conclusions is unclear.
During the course of the in vitro
 
 
 
studies described
above, we were generating MDCK cell lines that ex-
pressed constitutively active or dominant-negative Rac1
or RhoA under the control of the tetracycline repressible
transactivator (Gossen and Bujard, 1992). This expression
system has some advantages over microinjection, in which
the amount of protein expression is difficult to adjust and
analysis is confined to a small number of cells, and stably
transfected cell lines in which a fixed amount of protein is
constitutively expressed. Using tetracycline repressible ex-
pression, we have been able to examine short-term effects
of known amounts of RhoA mutants before, during, or af-
ter development of cell polarity. As controls, we used ei-
ther the same cell population grown in the presence of
doxycycline (DC) to repress RhoA mutant expression, or
added back DC to RhoA mutant expressing cells to exam-
ine the reversibility of disrupted cellular processes. Here
we report the characterization of these cells and show that
RhoA and Rac1 are involved at multiple levels in the de-
velopment of epithelial cell polarity; in the accompanying
study (Jou et al., 1998), we describe in detail the roles of
RhoA GTPases in regulating the structure and function of
the epithelial tight junction.
 
Materials and Methods
 
Plasmid Construction and Selection of MDCK Cell 
Lines Stably Expressing Mutant Small GTPases
 
pUMRhoAV14, pUMRhoAN19, pUMRac1V12, and pUMRac1N17,
which express NH
 
2
 
-terminal myc-tagged constitutively active RhoA, dom-
inantly negative RhoA, constitutively active Rac1, and dominantly nega-
tive Rac1, respectively, were generously provided by Dr. Rong-Guo Qiu
(Qiu et al., 1995
 
a
 
,
 
b
 
).
The parental MDCK T23 clone, which expresses the tetracycline-
repressible transactivator (Barth et al., 1997), was used to generate stable
lines expressing constitutively active and dominant-negative RhoA and
Rac1. Using lipofectamine (GIBCO BRL, Gaithersburg, MD), parental
T23 cells were cotransfected with expression vectors for small GTPase mu-
tants (pUMRhoAV14, pUMRhoAN19, pUMRac1V12, and pUMRac1N17)
and pHMR272, which carries the hygromycin resistance gene (Gossen and
Bujard, 1992). In brief, 0.5 
 
m
 
g of cesium chloride density gradient purified
mutant GTPase plasmid, 0.025 
 
m
 
g pHMR272, and 5 
 
m
 
l lipofectamine re-
agent were mixed in 200 
 
m
 
l of serum-free DME at room temperature for
45 min. The mixture was diluted with 800 
 
m
 
l serum-free DME and added
to T23 MDCK cells in six-well cluster plates; cells were in log phase
growth and had been incubated in 20 ng/ml DC (Sigma Chemical Co., St.
Louis, MO) for at least 48 h before transfection. After 9 h at 37
 
8
 
C, the me-
dium was replaced with DME containing 10% FBS (Gemini BioProducts,
Calabasas, CA) and 20 ng/ml DC, and the cells were incubated for a fur-
ther 24 h. The cells were then passaged to P-150 plates in medium contain-
ing 200 
 
m
 
g/ml hygromycin B (Calbiochem-Novabiochem Corp., La Jolla,
CA). After selection for 10 d, surviving colonies were isolated using clon-
ing rings, and mutant GTPase expression was assessed by either Western
blotting or immunofluorescence 36 h after removal of DC. Positive clones
were expanded in the presence of DC, aliquoted, and stored in liquid ni-
trogen. Parental T23 cells were also transfected with the empty pUHD10-3
vector and pHMR 272; eight clones were picked and pooled together to
form the mock transfection control (pUHD).
 
Cell Culture
 
Parental T23 cells and transfected cells were grown in DME containing
10% FBS and 20 ng/ml DC at 37
 
8
 
C in a humidified atmosphere containing
5% CO
 
2
 
. Cultures were routinely monitored for Mycoplasma infection.
Generally, maximum expression of mutant genes occurred 36 to 48 h
(RhoAV14, Rac1V12, Rac1N17) or 
 
.
 
48 h (RhoAN19) after removal of
DC from the culture medium. In calcium switch experiments, control and
mutant small GTPase-expressing cells were grown in the presence or ab-
sence of 20 ng/ml DC at low density, trypsinized, and plated onto Tran-
swell™ filters in medium containing 5 
 
m
 
M calcium (LCM) with or without
20 ng/ml DC. Cells were incubated in LCM for 4 h, gently rinsed twice in
prewarmed LCM, and then incubated in DME/FBS containing 1.8 mM
calcium (HCM) with or without 20 ng/ml DC.
 
Antibodies
 
The following antibodies were used: rabbit polyclonal anti–myc antibody
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA); mouse anti–myc hybri-
doma 9E10 (Dr. Gordon Cann, Stanford University Medical School, Stan-
ford, CA); mouse anti–GP135 hybridoma 3F2/D8 (Dr. George K.
Ojakian, SUNY Health Science Center, Brooklyn, NY); mouse anti–
Rac1, E-cadherin, 
 
a
 
-catenin, and 
 
b
 
-catenin antibody (Transduction Labo-
ratories, Lexington, KY); mouse anti–RhoA antibody (Santa Cruz Bio-
technology, Inc.); mouse anti–Glu-Glu hybridoma supernatant was a gift
from Dr. Marc Symons (Onyx Pharmaceuticals, Richmond, CA); rabbit
polyclonal anti–E-cadherin antibody was a gift from Dr. James Marrs (In-
 
1. 
 
Abbreviations used in this paper
 
: DC, doxycycline; ERM, ezrin-radixin-
moesin; PIP
 
2
 
, phosphatidylinositol (4,5)-bisphosphate. 
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diana University School of Medicine, Indianapolis, IN; Marrs et al., 1993);
rhodamine-conjugated phalloidin (Molecular Probes, Eugene, OR); rab-
bit polyclonal anti–rab11 antibody (Zymed Laboratories Inc., South San
Francisco, CA); and affinity-purified fluorescein- and rhodamine-labeled
secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA).
 
Immunofluorescence Microscopy
 
Confluent monolayers of MDCK cells were grown on rat tail collagen-
coated coverslips or Transwell™ filters (Corning Costar, Cambridge,
MA) in DME/FBS with or without 20 ng/ml DC. Cells were washed twice
with Dulbecco’s PBS (0.9 mM CaCl
 
2
 
, 2.7 mM KCl, 1.5 mM KH
 
2
 
PO
 
4
 
, 0.5 mM
MgCl
 
2
 
, 137 mM NaCl, and 8.1 mM Na
 
2
 
HPO
 
4
 
) and then fixed for 20 min at
room temperature in 3.7% paraformaldehyde in Dulbecco’s PBS. Cells
were then washed twice in Dulbecco’s PBS at room temperature for 10
min and extracted with CSK buffer (50 mM NaCl, 300 mM sucrose, 10 mM
Pipes, pH 6.8, 3 mM MgCl
 
2
 
, 0.5% [vol/vol] Triton X-100) at room temper-
ature for 10 min. Cells were washed twice in Dulbecco’s PBS at room tem-
perature for 10 min. Cells were blocked in Dulbecco’s PBS containing 1%
BSA, 10% goat serum, and 50 mM NH
 
4
 
Cl for 1 h at room temperature or
overnight at 4
 
8
 
C. After blocking, cells were washed briefly in Dulbecco’s
PBS and 0.2% BSA and then incubated in primary antibody solution for 1 h
at room temperature or overnight at 4
 
8
 
C. Cells were then washed three
times in Dulbecco’s PBS and 0.2% BSA and incubated in fluorescein- or
rhodamine-conjugated goat secondary antibody solution for 1 h at room
temperature. Cells were washed three times in Dulbecco’s PBS and 0.2%
BSA and mounted in either Elvanol (16.7% Mowiol, 33% glycerol, 0.1%
phenylenediamine) or Vectashield (Vector Laboratories, Inc., Burlin-
game, CA). Cells were viewed with an Axioplan epifluorescence micro-
scope (Carl Zeiss, Inc., Thornwood, NY), using either a 40 or 63
 
3
 
 oil im-
mersion objective, or a confocal laser scanning microscope (model
MultiProbe 2010; Molecular Dynamics, Mountain View, CA). Fluorescent
images of stained cells were recorded using Kodak (Rochester, NY) Ek-
tachrome Elite II (ASA 400) film. Photographic images were then digi-
tized with a slide scanner (Nikon, Inc., Melville, NY), and images were re-
sized, arranged, and labeled using Adobe Photoshop software (San Jose,
CA). The resulting images were printed from the computer file using a
Tektronix dye sublimation printer (Wilsonville, OR). The printed images
are representative of the original data.
 
Cell Extraction, Immunoprecipitation, 
and Immunoblotting
 
MDCK cells were grown on Transwell™ filters and extracted in 900 
 
m
 
l
Triton X-100 extraction buffer (0.5% [vol/vol] Triton X-100, 10 mM Tris-
HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, and 1.8 mM CaCl
 
2
 
) containing
25 mg/ml pepstatin A, 1 mM Pefabloc, 1 mM benzamidine, 1% aprotinin,
100 mM leupeptin, 1 mM sodium vanadate, and 50 mM NaF on a rocker
platform for 10 min at 4
 
8
 
C. Cells were scraped from the filter using a rub-
ber policeman and centrifuged at 12,000 
 
g
 
 for 15 min at 4
 
8
 
C; pellets were
dissolved in 100 
 
m
 
l SDS-IP buffer (1% SDS, 10 mM Tris-HCl, pH 7.5, 2 mM
EDTA) at 100
 
8
 
C and then diluted with 900 
 
m
 
l Triton X-100 extraction
buffer. Supernatants were adjusted with 100 
 
m
 
l SDS-IP buffer for direct
separation of proteins for Western blotting or were processed for immu-
noprecipitation (see below). Protein concentrations in supernatants and
pellets were determined using the BCA protein assay reagent kit (Pierce
Chemical Co., Rockford, IL). Equal amounts of total protein (reconsti-
tuted by addition of supernatant and pellet fraction from each sample), or
supernatant or pellet were separated by 7.5% SDS-PAGE, transferred
electrophoretically to nitrocellulose filters, and processed for immuno-
blotting with specific antibodies. Immune complexes were visualized with
donkey anti–rabbit and sheep anti–rat horseradish peroxidase–conjugated
secondary antibodies (Amersham Corp., Arlington Heights, IL) and de-
veloped using the ECL kit (Amersham Corp.). For protein immunopre-
cipitation, Triton X-100 lysate supernatants were incubated with anti–
E-cadherin (Ecad2) antibody, and immune complexes were isolated with
protein A–Sepharose (Pharmacia Biotech, Piscataway, NJ). Immunopre-
cipitates were washed with high stringency buffer (HS-B: 20 mM Tris-
HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, 5 mM EDTA, 5 mM EGTA,
0.1% SDS, 1% Na-deoxycholate, 0.5% Triton X-100), followed by high
salt wash buffer (HS-B containing 1M NaCl), and samples were then re-
solved by SDS-PAGE and processed for Western blotting as described
above. Chemiluminescent signals were collected and scanned from auto-
radiography film (Kodak) with a Hewlett-Packard Scan-Jet IIc scanner
(Greeley, CO) into Adobe Photoshop. Intensities of signals were mea-
sured by NIH Image 1.58 software. For figures, the contrast of images was
adjusted, arranged, and labeled in Adobe Photoshop. The resulting im-
ages were printed using a Tektronix dye sublimation printer (Wilsonville,
OR). The printed images are representative of the original data.
 
Results
 
Rac1V12 Induces Lamellipodia Formation and MDCK 
Cell Scattering, but Rac1N17 Induces Compaction of 
MDCK Cell Colonies
 
T23 MDCK cells, which stably express the tetracycline
transactivator (Barth et al., 1997), were cotransfected with
either NH
 
2
 
-terminal tagged myc-RhoAV14 (constitutively
active RhoA mutant), -RhoAN19 (dominant-negative RhoA
mutant), -Rac1V12 (constitutively active Rac1 mutant), or
-Rac1N17 (dominant-negative Rac1 mutant) and pHMR272
(hygromycin B resistance). Four clones expressing
RhoAV14, five clones expressing RhoAN19, three clones
expressing Rac1V12, and four clones expressing Rac1N17
were isolated. Expression of each RhoA or Rac1 mutant
was confirmed by immunofluorescence microscopy and
Western blotting. Clones were chosen for further analysis
based upon the homogeneity and amount of protein ex-
pression.
In the first series of experiments, we characterized the
cellular effects of (
 
a
 
) a gradual increase in amounts of
RhoA and Rac1 mutants (Fig. 1); (
 
b
 
) long-term expression
(3 wk) of Rac1V12 and Rac1N17 (Fig. 2); and (
 
c
 
) a DC
dose-specified range of fixed amounts of RhoA or Rac1
mutants (Fig. 3). Antibodies that recognized endogenous
Rac1 or RhoA were used in Western blots of cell extracts
to monitor simultaneously the amounts of mutant and en-
dogenous protein; because of the myc-tag, RhoA and
Rac1 mutants had a slower electrophoretic mobility than
endogenous RhoA and Rac1. We note that interpretation
of observed changes in cellular phenotype is complicated
not only by the increasing level of mutant small GTPase,
but also by the increasing time that the cells were exposed
to mutant protein. Nevertheless, these initial observations
provide important, first insights into early changes in epi-
thelial cell organization in response to mutant GTPase ex-
pression. Note that this first set of experiments should be
compared with those presented in Fig. 3, in which different
but constant levels of mutant small GTPases were ex-
pressed for the same length of time.
First, cells were grown in DME/FBS and 20 ng/ml DC to
repress RhoA or Rac1 mutant expression. Cells were then
plated at low cell density in the absence of DC, the accu-
mulation of each RhoA or Rac1 mutant was monitored in
Western blots, and the effects of mutant expression on cell
morphology were examined by phase contrast microscopy
(Fig. 1, 
 
A
 
 and 
 
B
 
). In the presence of 20 ng/ml DC (0 h),
Rac1V12 was not expressed, and cells formed small colo-
nies of adherent cells with few membrane ruffles or lamel-
lipodia, similar to normal MDCK cells (Fig. 1 
 
A
 
). After re-
moval of DC, the amount of Rac1V12 accumulated from
10% (12 h), to 40% (24 h), 85% (36 h), and finally 95%
(48–60 h) of the level of endogenous Rac1. Note that dur-
ing this time, the amount of endogenous Rac1 remained
approximately constant (Fig. 1 
 
A
 
). During the accumula-
tion of Rac1V12, the morphology of cells and colonies 
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changed. The first effects were apparent at 24 h as cells
formed prominent lamellipodia and appeared to have
spread out more on the substratum. These changes be-
came more pronounced at later times. At 60 h, colonies of
cells were still intact, but the cells were flat with promi-
nent, broad lamellipodia at cell surfaces not in contact
with other cells (Fig. 1 
 
A
 
; note that the magnification is
greater than in the other images).
The kinetics of Rac1N17 accumulation and the effects
on cell morphology were different from those of Rac1V12.
Initially, Rac1N17 accumulated to 
 
z
 
20% of endogenous
Rac1 protein level 12 h after removal of DC, but then the
amount increased quickly to 
 
z
 
220% (24 h), 
 
z
 
350% (36 h),
and finally 
 
.
 
600% of endogenous Rac1 (Fig. 1 
 
A
 
). The
amount of endogenous Rac1 remained constant for 60 h
and then decreased by 
 
z
 
60%. Cellular effects were de-
tected after 24 h as cells became less spread on the substra-
tum and rounded-up, and colonies became increasingly
compacted.
A similar analysis of the effects of RhoA mutant accu-
mulation on cell morphology is shown in Fig. 1 
 
B
 
. After 12 h,
the level of RhoAV14 was not above background (Fig. 1
 
B
 
). RhoAV14 accumulated to 10% (24 h), 70% (36 h),
100% (48 h), and finally 150% (60 h) of endogenous
RhoA. The amount of endogenous RhoA remained con-
stant, but finally decreased by 
 
z
 
25% at 60 h (Fig. 1 
 
B
 
).
During this time, cells remained associated in colonies, but
membrane ruffles and lamellipodia at colony edges be-
came more frequent, and translucent gaps formed be-
tween cells within colonies (Fig. 1 
 
B
 
).
RhoAN19 accumulated slowly in cells and the maximum
level of expression relative to the endogenous RhoA level
Figure 1.( A ) Time course of Rac1V12 and Rac1N17 expression in MDCK cells and effects on the cell morphology in low-density cul-
tures. Low-density cultures of Rac1V12 (left) and Rac1N17 (right) MDCK cells were grown in the absence of DC for the indicated
times. (Top) At each time, cells were lysed in SDS sample buffer and processed for Western blotting with an anti-Rac1 monoclonal an-
tibody to detect induction of mutant protein and levels of endogenous protein. *Note that addition of the myc epitope tag to Rac1V12
and Rac1N17 caused them to migrate more slowly than endogenous Rac1. (Bottom) Phase contrast micrographs of cell colonies at dif-
ferent times after Rac1V12 or Rac1N17 induction. (B) Time course of RhoAV14 and RhoAN19 expression in MDCK cells and effects
on the cell morphology in low-density cultures. Low-density cultures of RhoAV14 (left) and RhoAN19 (right) MDCK cells were grown
in the absence of DC for the indicated times. (Top) At each time, cells were lysed in SDS sample buffer and processed for Western blot-
ting with an anti-RhoA monoclonal antibody to detect induction of mutant protein and levels of endogenous protein. *Note that addi-
tion of the myc epitope tag to RhoAV14 and RhoAN19 caused them to migrate more slowly than endogenous RhoA. (Bottom) Phase
contrast micrographs of cell colonies at different times after RhoAV14 or RhoAN19 induction. Bars, 10 mm. 
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was lower than that of other RhoA and Rac1 mutants.
RhoAN19 was detected at 
 
z
 
15% (24 h), 60% (36–48 h),
and finally 45% (60 h) of endogenous RhoA (Fig. 1 
 
B
 
).
The amount of endogenous RhoA increased by 
 
z
 
25%.
During expression of RhoAN19, cells became more spread
on the substratum, ruffled membrane and lamellipodia
were detected, and cell colonies became less circular and
more elongated and fibroblastic in overall shape (Fig. 1 
 
B
 
).
 
Effects of Prolonged Overexpression of Rac1 Mutants in 
MDCK Cells
 
Recent studies of RhoA mutants in epithelial cells have
used constitutive expression vectors driven by a viral pro-
moter (Takaishi et al., 1997). For comparison, we exam-
ined effects of long-term expression of Rac1V12 and
Rac1N17 in cells grown in the absence of DC for up to 3 wk.
Rac1V12 accumulated to a level similar to that of endoge-
nous Rac1 after 36 h (Fig. 2; see also Fig. 1 
 
A
 
) and then re-
mained at that level for 3 wk (Fig. 2). Rac1V12 cell mor-
phology was different from that of control cells grown in
the presence of DC to repress Rac1V12 expression.
Rac1V12 cells remained in colonies, but the cells were flat-
tened onto the substratum and had abundant lamellipodia;
 
,
 
5% of cells formed compact colonies similar to control
(data not shown). The morphology of Rac1V12 cells at 3 wk
was similar to the cell morphology after 36 h (see Fig. 1 
 
A
 
),
indicating that short- and long-term expression of this mu-
tant had similar effects.
Rac1N17 accumulated to 
 
.
 
400% of the amount of en-
dogenous Rac1 after 36 h (Fig. 2), as reported above (see
Fig. 1 
 
A
 
), but then decreased to background levels after 1 wk
(Fig. 2). Rac1N17 cells had a similar morphology whether
DC was present or not after 3 wk (Fig. 2). We expect that
Rac1N17 high expressing cells were lost from the cell pop-
ulation because either they attached poorly to the substra-
tum (Lee, R., and T.-S. Jou, unpublished result) or Rac1N17
suppressed cell growth (Qiu et al., 1995), which could al-
low a population of firmly attached, faster growing cells to
quickly dominate the culture. These results further under-
line the usefulness of tetracycline repressible gene expres-
sion for these studies.
 
Subcellular Distributions and Dose-dependent Effects 
of Rac1 and RhoA Mutants on the Actin Cytoskeleton 
in MDCK Cells
 
The results described above show that the gradual accu-
mulation of RhoA and Rac1 mutants led to concomitant,
mutant protein concentration-dependent changes in cellu-
lar morphology. In the next series of experiments, we ex-
amined the effects of fixed amounts of RhoA or Rac1 mu-
tants on cell morphology, the subcellular distribution of
RhoA and Rac1 mutants, and the organization of F-actin.
In these experiments, amounts of RhoA and Rac1 mutants
were titrated by growing cells in different concentrations
of DC. Relative amounts of mutant and endogenous
RhoA or Rac1 were determined by Western blotting with
antibodies that recognized Rac1 or RhoA, and the distri-
bution of each RhoA or Rac1 mutant protein was deter-
mined with an antibody that recognized the myc epitope
tag (Fig. 3, 
 
A–D
 
).
Levels of Rac1V12 increased from 20% in 20 pg/ml DC,
to 
 
z
 
45% in 4.0–0.8 pg/ml DC, to 100% 
 
2
 
DC compared
with endogenous Rac1. Levels of endogenous Rac1 did
not change (Fig. 3 
 
A
 
). Rac1V12 protein was first detected
(20 pg/ml DC) at cell–cell contacts and continued to accu-
mulate there even when the amount of Rac1V12 had in-
creased 5
 
3
 
 higher (
 
2
 
DC). Significantly less protein was
detected on the membrane in areas not in contact with
other cells (Fig. 3 
 
A
 
). Generally, cells appeared more flat-
tened on the substratum in the presence of increasing
amounts of Rac1V12, as described above (Fig. 1 
 
A
 
). We
detected clear changes in F-actin organization as the
Rac1V12 level increased. Initially, in the absence of
Rac1V12 expression (20 ng/ml DC), F-actin was promi-
nently localized in stress fibers at the base of cells and in
thick cortical bundles at the edge of cells (Fig. 3 
 
A
 
). With
increasing amounts of Rac1V12, F-actin was no longer
clearly organized into stress fibers, and thick cortical bun-
dles of actin were sharper in profile and lined up next to
cell–cell contacts (Fig. 3 
 
A
 
).
Rac1N17 accumulated to levels 10–20 times that of en-
dogenous Rac1 at all DC concentrations below 20 pg/ml.
Note that at the same time, levels of endogenous Rac1 de-
Figure 2. Effects of long-term expression of Rac1V12 and
Rac1N17 on mutant protein expression and MDCK cell morphol-
ogy. Rac1V12 and Rac1N17 MDCK cells were cultured in the
presence of DC, 0 d, or in absence of DC for 1.5, 7, or 21 d. (Top)
At each time, cell lysates were analyzed by Western blotting with
an anti-Rac1 antibody to assess the expression of Rac1V12 or
Rac1N17, and endogenous Rac1. *Note that addition of the myc
epitope tag to Rac1V12 and Rac1N17 caused these proteins to
migrate more slowly than endogenous Rac1. (Bottom) Phase con-
trast micrographs of Rac1V12 and Rac1N17 cells grown in the
presence (1DC) or absence of DC (2DC) for 21 d. Bar, 10 mm. 
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creased by 
 
z
 
50% (Fig. 3 
 
B
 
). Cells became smaller in pro-
file and colonies became tightly compacted (Fig. 3 
 
B
 
), as
described above (see Fig. 1 
 
A
 
). Rac1N17 localized to cell–
cell contacts, and little or no protein accumulated at the
edges of cells not in contact with other cells. Some in-
creased diffuse staining of Rac1N17 was also detected in
the cytoplasm. The instant high levels of Rac1N17 in 20
pg/ml DC caused F-actin to become localized to cell–cell
contacts. However, because of the highly compacted orga-
nization of colonies, it was difficult to determine if other
aspects of F-actin organization had changed (see below).
RhoAV14 began to accumulate to 5% of endogenous
RhoA at 200 pg/ml DC, to 
 
z
 
30% in 0.8 pg/ml DC, to 50%
in 20 pg/ml DC, to 180% in 4 pg/ml DC, and to .200% in
0.8 pg/ml DC (Fig. 3 C). RhoAV14 was localized in the cy-
toplasm, was excluded from the nucleus, and did not ap-
pear to accumulate at cell–cell contacts (Fig. 3 C). With in-
creasing amounts of RhoAV14, F-actin bundles at the
base of the cell and at the cell cortex appeared to become
thicker and more prominent.
RhoAN19 was detected at concentrations of DC below
20 pg/ml and accumulated to 20% of endogenous RhoA in
20 pg/ml, to 60% in 4 pg/ml, and to 140% in 0.8 pg/ml (Fig.
3 D). We detected an z50% decrease in the amount of en-
dogenous RhoA when RhoAN19 was expressed at maxi-
mal level (Fig. 3 D). RhoAN19 was localized to the cyto-
plasm and did not accumulate at cell–cell contacts (Fig. 3
D). Despite high levels of RhoAN19, we detected few
gross changes in the organization of F-actin, which re-
mained localized in stress fibers and cortical bundles at the
edges of cells (Fig. 3 D).
Effects of Rac1 and RhoA Mutants on Cellular 
Morphology and F-Actin Organization in Confluent 
Monolayers of Polarized MDCK Cells
We next examined the effects of RhoA and Rac1 mutants
on cellular organization and F-actin distributions in con-
fluent monolayers of MDCK cells. 18 h after induction of
cell–cell contacts, a monolayer that formed in the presence
Figure 3. Dose-dependent effects of Rac1V12 (A), Rac1N17 (B), RhoAV14 (C), and RhoAN19 (D) on the subcellular distributions of
mutant protein (myc-tagged), F-actin distribution (phalloidin), and cell morphology. Low-density MDCK cells were grown for 40 h in
the presence of different concentrations of DC. (Top) After 40 h, cell lysates were analyzed by Western blotting with a mouse anti-Rac1
or RhoA antibody to assess the expression of mutant protein (*) and endogenous protein. The number above each lane refers to the
concentration of DC shown on the left hand side. (Bottom) After 40 h, cells were fixed and double stained with a mouse anti-myc anti-
body to detect mutant RhoA or Rac1, and phalloidin to detect F-actin. Bar, 10 mm.Jou and Nelson RhoA Functions in Epithelial Polarity 91
of DC contained cells that were organized into a regular,
cobble-stone pattern (Fig. 4, RhoAV141DC). Confocal
microscopy of these cells stained with phalloidin showed
that F-actin was organized into an intensely staining cir-
cumferential belt at the apex of the lateral membrane in
the region of the apical junctional complex, down lateral
membrane at cell–cell contacts, and in weakly staining
stress fibers at the base of cells close to the substratum
(Fig. 4, RhoAV141DC).
RhoAV14-expressing MDCK cells also established a
continuous monolayer, but the cells were larger and more
fusiform than control cells and were irregularly arranged in
the monolayer with clear gaps between cells; groups of cells
also grew on top of the monolayer (Fig. 4, RhoAV142DC).
F-actin was prominently localized to cell–cell contacts at
the apical surface, but the staining was more diffuse than
that in control cells. F-actin staining was particularly
strong at the base of cells in the form of stress fibers (Fig.
4, RhoAV142DC). In contrast, RhoAN19 expressing
MDCK cell monolayers appeared similar to the controls,
as these cells formed a regular organization and F-actin
was strongly localized to cell–cell contacts (Fig. 4,
RhoAN192DC).
Rac1V12-expressing MDCK cells established a mono-
layer of regularly organized cells similar to the control
(Fig. 4, Rac1V122DC). At the apical surface, however,
F-actin was not only organized at cell–cell contacts, as in
the control, but also in large aggregates in the plane of the
apical membrane. Lower down the lateral membrane and
at the base of these cells, F-actin was present mostly at
cell–cell contacts. Only a few if any stress fibers were visi-
ble (Fig. 4, Rac1V122DC). Rac1N17-expressing cells
formed a monolayer of uniformly normal-shaped cells
(Fig. 4, Rac1N172DC). F-actin was prominently localized
to the cell–cell contacts at the apex of the lateral mem-
brane. Further down the lateral membrane and at the base
of these cells, the F-actin organization was unusually
beaded at cell–cell contacts, and there appeared to be few
if any stress fibers.
In summary, in confluent cell monolayers expression of
RhoA mutants caused a different set of changes in F-actin
organization than did Rac1 mutants. RhoAV14 induced
more stress fiber formation, as at low cell density. In con-
trast, both Rac1V12 and Rac1N17 induced an unusual
beaded pattern of F-actin on the lateral membrane, although
this type of organization was not obvious in cells grown at a
low density. In confluent monolayers, F-actin in Rac1V12
cells was also localized in an unusual beaded pattern at the
apical membrane. These changes in F-actin distributions
prompted us to examine the distributions of actin-associ-
ated apical (GP135) and basal–lateral (E-cadherin) mem-
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Rac1V12 or Rac1N17 Expression Causes Intracellular 
Aggregation of E-Cadherin/F-Actin and GP135/F-Actin 
at Different Cell Densities
E-cadherin and GP135 distributions were examined in
MDCK cells expressing RhoA or Rac1 mutants at a range
of cell densities (Fig. 5). Rac1V12 cells had a flattened
morphology at low cell density, as shown above (Fig. 1 A).
Double fluorescence showed colocalization of Rac1V12
(anti-myc tag antibody) and E-cadherin at the membrane
of cell–cell contacts (Fig. 5, a and a9). Note that both pro-
teins were excluded from regions of the plasma membrane
that were not in contact with other cells. As the cell den-
sity increased, Rac1V12 remained at cell–cell contacts, but
discontinuities in the staining at those contacts were evi-
dent (Fig. 5 b). At high cell density, Rac1V12 was located
in finely beaded arrays at cell–cell contact sites and in
large (intracellular) aggregates (Fig. 5 c9). These Rac1V12
aggregates colocalized with GP135 (Fig. 5, c and c9) and
with F-actin (see also Fig. 4). Antibodies to extracellular
epitopes on GP135 only reacted with these aggregates
when cells had been permeabilized with Triton X-100
(data not shown), indicating that the aggregates were in-
tracellular.
Rac1N17 cells were grown at either a low density (Fig. 5,
d and f) or in medium containing 5 mM Ca21 (LCM; see
Materials and Methods) to inhibit E-cadherin–mediated
Figure 4. F-actin distribution and morphology of confluent monolayers of control (RhoAV141DC) and RhoA and Rac1 mutant–
expressing MDCK cells (2DC). RhoAV14, RhoAN19, Rac1V12, and Rac1N17 MDCK cells were grown in the presence (control; first
column) or absence (all other columns) of DC at low cell density for 24 h, trypsinized and plated in LCM for 3 h, and then cultured for
16 h in HCM to induce cell–cell adhesion (1/2DC). (Top) Phase contrast micrographs of cells. (Middle) Cells were fixed and stained
with phalloidin and examined by confocal microscopy: xy sections at the level of the apical junction (Apical Section), and basal mem-
brane (Basal Section). (Bottom) xz sections of cell monolayers. Bar, 10 mm.
cell–cell adhesion (Fig. 5 e). At low cell densities, Rac1N17
was localized in large aggregates inside cells that colocal-
ized with F-actin (Fig. 5 d9) and E-cadherin (Fig. 5 e9), but
not GP135 (data not shown). In addition to these aggre-
gates, Rac1N17, E-cadherin, and F-actin also colocalized
at cell–cell contacts in finely beaded arrays (Fig. 5, d–f). In
intermediate-density cultures containing colonies of .15
cells, Rac1N17/E-cadherin aggregates were often enriched
at the free margins of cells and diminished greatly in num-
ber in cells that were completely surrounded by other cells
(Fig. 5, g and g9). In high-density cultures, intracellular
Rac1N17 aggregates were no longer visible (Fig. 5 h), and
Rac1N17 was localized in a finely beaded pattern at cell–
cell contacts, similar to that of F-actin (Fig. 4) and E-cad-
herin/b-catenin (see Fig. 7 A).
In Polarized Cell Monolayers, RhoA and Rac1 Mutants 
Do Not Affect E-Cadherin/b-Catenin Distribution, but 
Rac1 Mutants Affect the Localization of GP135
The preceding results show that RhoA and Rac1 mutants
affect the distributions of F-actin, E-cadherin, and GP135
during initial stages in the formation of a confluent cell
monolayer and the development of epithelial cell polarity.
We next examined the organization of E-cadherin and GP135
in confluent monolayers of polarized MDCK cells grown
on Transwell™ filters. Steady-state levels of E-cadherinJou and Nelson RhoA Functions in Epithelial Polarity 93
and the associated cytoplasmic proteins a- and b-catenin
were analyzed by Western blotting of E-cadherin–specific
coimmunoprecipitates (Fig. 6). Little or no change in levels
of any of these proteins was detected between matched pairs
of controls (1DC) and RhoA or Rac1 mutant cells (2DC).
Confocal microscopy showed that E-cadherin and
b-catenin were localized to the lateral membrane of con-
trol cells (Fig. 7 A, RhoAV141DC) and of all cells ex-
pressing RhoA or Rac1 mutants (2DC). In all cases, little
or no E-cadherin or b-catenin was detected at either the
apical or basal membrane (Fig. 7 A). However, careful ex-
amination of the staining patterns revealed that the distri-
bution of E-cadherin in cells expressing RhoAV14
(2DC), Rac1V12 (2DC), and Rac1N17 (2DC) was dif-
ferent from that in the control (RhoAV141DC) and
RhoAN192DC cells (Fig. 7 A). In RhoAV14 cells, E-cad-
herin and b-catenin staining were more diffuse at the
membrane (Fig. 7 A), similar to that of F-actin in these
cells (Fig. 4). In Rac1V12 and Rac1N17 cells, E-cadherin
and b-catenin staining revealed a finely beaded pattern at
cell–cell contacts (Fig. 7 A), similar to the distribution of
F-actin on the lateral membrane of these cells (Fig. 4).
Fig. 7 B shows apical membrane xy sections (left) and
confocal xz sections (right) of MDCK monolayers stained
with antibodies to E-cadherin and GP135. The xy sections
show that GP135 has a finely granular staining pattern on
the apical surface of control cells (RhoAV141DC), and
the xz section of these cells shows that GP135 is restricted
to the apical surface and excluded from lateral membranes
containing E-cadherin, as expected (Ojakian and Schwim-
Figure 6. Protein levels of the E-cadherin, b-catenin, and a-cate-
nin complex in cells expressing Rac1 or RhoA mutants. Rac1V12,
Rac1N17, RhoAV14, and RhoAN19 MDCK cells were grown on
Transwell™ filters for 16 h in the presence (lanes labeled 1, con-
trol) or absence (lanes labeled 2) of DC and then processed for
immunoprecipitation with E-cadherin antibody followed by
Western blotting of the coimmunoprecipitated complex with an-
tibodies specific for E-cadherin, b-catenin, or a-catenin.
Figure 5. Colocalization of Rac1 mutants with either E-cadherin or GP135, depending on cell density. Rac1V12 and Rac1N17 cells were
cultured without DC for 16 h at low (a, a9, d, d9, e, e9, and f), intermediate (b, g, and g9), or high cell density (c, c9, and h) in LCM (e and
e9) or HCM (a, a9, b, c, c9, d, d9, f, g, g9, and h). Cells were fixed and processed for immunofluorescence microscopy with anti-myc (a, b,
c9, d, e, f, g, and h) and either anti–E-cadherin (a9, e9, and g9) or anti-GP135 (c) antibodies, or FITC phalloidin (d9). Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 94
mer, 1988). In RhoAV14 (2DC) expressing cells, GP135
staining was different from that in control cells. Relatively
little GP135 was detected at the apical surface, and the
majority of GP135 staining appeared to be either associ-
ated with the lateral membrane or in intracellular aggre-
gates. In contrast, GP135 staining in RhoAN19 (2DC) ex-
pressing cells appeared very similar to that in control cells.
In Rac1V12 (2DC) expressing cells, GP135 staining was
Figure 7.( A ) Distribution of
E-cadherin and b-catenin in
confluent monolayers of control
(RhoAV141DC) and RhoAV14
(2DC), RhoAN19 (2DC),
Rac1V12 (2DC), and Rac1N17
(2DC) expressing MDCK cells.
RhoAV14, RhoAN19, Rac1V12,
and Rac1N17 MDCK cells were
grown in the presence (control;
left column) or absence (all other
columns) of DC at low cell den-
sity for 24 h, trypsinized and
plated in LCM for 3 h, and then
cultured for 16 h in HCM to in-
duce cell–cell adhesion (with or
without DC). After fixation, cells
were stained with anti–E-cadherin
(top) and b-catenin (bottom) an-
tibodies and then examined in a
confocal microscope. xy sections
(large panels), at the level of api-
cal junction, and xz sections are
shown. (B) Distributions of
E-cadherin and GP135 in con-
fluent monolayers of control
(RhoAV141DC) and RhoAV14
(2DC), RhoAN19 (2DC),
Rac1V12 (2DC), and Rac1N17
(2DC) expressing MDCK cells.
RhoAV14, RhoAN19, Rac1V12,
and Rac1N17 MDCK cells were
grown in the presence or ab-
sence of DC at low cell density
for 24 h, trypsinized and plated
in LCM for 3 h, and then cul-
tured for 16 h in HCM to induce
cell–cell adhesion (1/2DC). Af-
ter fixation, cells were costained
with anti–E-cadherin (TRITC,
red) and anti-GP135 (FITC,
green) antibodies. xy sections
(left, GP135 only) were collected
by epifluorescence microscopy,
and  xz sections (right, E-cadherin
and GP135) were collected by
confocal microscopy. Bars: (A) 5
mm; (B) 10 mm.Jou and Nelson RhoA Functions in Epithelial Polarity 95
clearly abnormal compared with controls and appeared
aggregated near the apical membrane, similar to the orga-
nization of F-actin in these cells (Fig. 4). Antibodies to ex-
tracellular epitopes on GP135 only reacted with these ag-
gregates when cells had been first permeabilized with
Triton X-100 (data not shown), indicating that the aggre-
gates were intracellular. In contrast, in Rac1N17 (2DC)
expressing cells, GP135 staining was restricted to the api-
cal membrane as in controls, although the fine granular
staining was excluded from the center of the apical mem-
brane.
Fig. 8 shows a comparison of the distributions of GP135,
Rac1V12 (myc), F-actin (phalloidin), and rab11, a member
of the rab family of small GTPases that regulates vesicle
delivery to target membranes (Lazar et al., 1997; Novick
and Zerial, 1997). In Rac1V12 cells grown in the presence
of DC (1DC), rab11 was diffusely distributed in the cyto-
plasm, although an occasional bright aggregate of staining
was observed. Double immunofluorescence of Rac1V12
cells grown in the absence of DC (2DC) shows that rab 11
and Rac1V12 colocalized in a single, large aggregate local-
ized in the center of each cell. Note that the rab11 staining
was no longer diffuse in the cytoplasm of these cells. The
intensity of rab11 staining in the central aggregate corre-
lated positively with the intensity of Rac1V12 staining in
the higher expressing cells. Fig. 8 also shows that GP135
and F-actin colocalized in the same aggregates.
Mutant RhoA Dominates Rac1 in Controlling Actin 
Cytoskeleton Organization and Cell Shape in Doubly 
Transfected MDCK Cells
Microinjection studies in Swiss fibroblasts have revealed
that RhoA is downstream of Rac1 in a signaling pathway
(Hall, 1998). However, it is still not clear whether the same
signaling hierarchy exists in cell types other than fibro-
blasts. To test this possibility, we transiently transfected
RhoAN19 or RhoAV14 tagged with a Glu-Glu epitope
into either the Rac1V12- or the Rac1N17-expressing cell
line (Fig. 9). In the presence of RhoAN19, Rac1V12 was
no longer localized to cell–cell contacts but was present in
the cytoplasm. Furthermore, in the presence of RhoAN19
and Rac1V12, actin filaments were less prominent at the
cell periphery and more clearly incorporated into stress fi-
bers at the base of the cell, and the cells became slightly
more flattened onto the substratum. Both phenotypes
were characteristic of RhoAN19 cells (see Fig. 1). Expres-
sion of RhoAV14 in Rac1N17-expressing cells also caused
the loss of Rac1N17 from cell–cell contacts. The organiza-
tion of F-actin and the morphology of cells coexpressing
Figure 8. Distributions of rab11, Rac1V12-myc, GP135, and F-actin in monolayers of control cells (Rac1V12 1DC) or Rac1V12 (2DC)
expressing MDCK cells. Rac1V12 MDCK cells were grown in the presence (1DC, control) or absence (2DC) of DC at low cell density
for 24 h, trypsinized and plated in LCM for 3 h, and then cultured for 16 h in HCM to induce cell–cell adhesion (1/2DC). After fixation,
cells were costained with anti-myc (TRITC, red) and anti-rab11 (FITC, green) antibodies, or TRITC-phalloidin (red) and anti-GP135
(FITC, green) antibody; double exposures for myc/rab11 and phalloidin/GP135 are shown on the right. xy sections were collected by epi-
fluorescence microscopy. Bars, 10 mm.The Journal of Cell Biology, Volume 142, 1998 96
Rac1N17 and RhoAV14 also resembled those in RhoAV14-
expressing cells. Cells doubly expressing Rac1V12 and
RhoAV14 exhibited a distribution of F-actin more similar
to that in RhoAV14-expressing cells. These data indicate
that Rac1 and RhoA are not hierarchically ordered in the
same pathway in these cells but act independently on simi-
lar targets.
Discussion
Regulated Expression of RhoA and Rac1 Mutants in 
MDCK Cells
We have characterized cell lines that express RhoA or
Rac1 mutants in MDCK cells under control of the tetracy-
cline repressible transactivator. To our knowledge, this se-
ries of studies is the first to directly compare amounts of
expressed RhoA or Rac1 mutant protein with endogenous
RhoA or Rac1 and to compare the effects of a range of
known amounts of RhoA or Rac1 mutant proteins on cell
structure and function. Although we compared expression
levels of mutant RhoA and Rac1 with levels of the equiva-
lent endogenous proteins, the antibodies that recognized
endogenous RhoA or Rac1 could not distinguish between
the GDP- or GTP-bound forms of these small GTPases.
However, we note that a previous analysis of the relative
amounts of GDP- and GTP-bound forms of Rac1 in fibro-
blasts showed that only a very small portion of the total pro-
tein was GTP bound in resting cells (Hawkins et al., 1995).
The tetracycline repressible system enabled us to tightly
regulate levels of RhoA and Rac1 mutant expression. In
the presence of more than 20 ng/ml DC, expression of all
RhoA and Rac1 mutant genes was fully repressed, and no
protein accumulated (Fig. 1, A and B), thereby providing
an important control for these studies. At DC concentra-
tions below 20 ng/ml, Rac1V12, Rac1N17, and RhoAV14
accumulated gradually to levels similar to, or greater than
those of endogenous RhoA or Rac1. In the case of
RhoAN19, protein levels did not increase above 60% of
endogenous RhoA (Fig. 1, A and B). During the accumu-
lation of RhoA or Rac1 mutant protein, amounts of en-
dogenous RhoA or Rac1 remained constant for z48 h, un-
til maximum levels of mutant protein were expressed.
After 60 h, amounts of endogenous Rac1 decreased by
z60% in the presence of Rac1N17, and RhoA decreased
by  z25% or increased by z25% in the presence of
RhoAV14 and RhoAN19, respectively. At present, we do
not understand how or why endogenous RhoA and Rac1
levels changed under these conditions. It is possible that
transcriptional or posttranslational regulation of endoge-
nous RhoA and Rac1 levels is sensitive to the total
amount of RhoA or Rac1 in the cell, or the availability of
targets or regulators (e.g., GAP, GEF).
We found that amounts of RhoA or Rac1 mutants well
below those of endogenous RhoA or Rac1 disrupted cell
structure and organization. Cellular changes were observed
with amounts of Rac1V12, RhoAV14, and RhoAN19 that
were 40, 10, and 15%, respectively, of endogenous Rac1 or
RhoA. We did not determine a “minimal” expression level
of Rac1N17 that affected cellular organization since its
level increased sharply to .200% of endogenous Rac1 at
DC concentrations below 20 ng/ml (Fig. 1 A).
How can substoichiometric amounts of RhoA or Rac1
mutants compete with endogenous RhoA and Rac1 to
cause changes in cellular organization? One possibility is
that RhoA or Rac1 mutants simply bind to available tar-
gets, regulators or effectors that are in excess of the
amount of endogenous RhoA or Rac1. In this case, the ef-
fects of an initially small amount of mutant GTPase would
be diluted by the surrounding population of active GTP-
ase. Alternatively, or in addition, RhoA or Rac1 mutants
bind to sites made available by the rapid cycling of endog-
enous RhoA or Rac1 on and off that binding site and then
remain there, because dissociation from that site is inhib-
ited by the mutation, thereby blocking the rebinding of en-
dogenous RhoA or Rac1. In this case, mutant GTPases
would rapidly displace normal GTPase from binding sites
and accumulate, thereby resulting in quick domination of
the mutant phenotype. There is indirect evidence in sup-
Figure 9. Distribution of RhoA and Rac1 mutants, and F-actin in
MDCK cells expressing combinations of Rac1V12, Rac1N17,
RhoAV14, and RhoAN19. Rac1V12 (myc) expressing cells were
transiently supertransfected with either RhoAN19 tagged with a
Glu-Glu epitope (EE) or RhoAV14 tagged with a Glu-Glu
epitope (EE). After 24 h, cells were fixed and stained with anti–
Glu-Glu epitope tag antibody (EE) to detect cells that expressed
RhoAN19 or RhoAV14, and double stained with either myc
epitope antibody (myc) or phalloidin to detect Rac1V12 and
F-actin, respectively. Rac1N17 (myc) expressing cells were tran-
siently supertransfected with RhoAV14 tagged with a Glu-Glu
epitope (EE), stained with antibody recognizing Glu-Glu epitope
tag (EE), and double stained with either myc epitope antibody
(myc) or phalloidin to detect Rac1N17 and F-actin, respectively.
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port of the second possibility: (a) RhoA GTPases quickly
cycle between active (GTP-bound) and inactive (GDP-
bound) states (Bourne, 1993); (b) Tiam-1, a nucleotide ex-
change factor for RhoA GTPases, is localized to cell–cell
contacts in MDCK cells (Hordijk et al., 1997); and (c) re-
covery of normal functions after repression of RhoA or
Rac1 mutant expression is delayed by z12 h, indicating
that mutant proteins can block activities of endogenous
RhoA or Rac1 for long periods (Jou et al., 1998).
An important question is whether Rac1 and RhoA
share downstream effectors. We note that both Rac1V12
and Rac1N17 were localized prominently to cell–cell con-
tacts, whereas RhoAV14 and RhoAN19 were located in
the cytoplasm (see also Takaishi et al., 1997). Despite
these different distributions, we found that coexpression
of RhoAN19 in a Rac1V12 background or RhoAV14 in
either a Rac1V12 or Rac1N17 background caused delocal-
ization of Rac1 mutants to the cytoplasm and resulted in
cell flattening on the substratum and formation of promi-
nent actin stress fibers, both of which are characteristics of
RhoAN19 and RhoAV14 cells. These results could be in-
terpreted as showing that active RhoA is required for
Rac1 function, similar to that drawn from the study of ke-
ratinocytes comicroinjected with C3 transferase and an ac-
tivated form of Rac1 (Braga et al., 1997). However, we
were also able to ask this question in a different way by co-
expressing RhoAV14 in a Rac1V12 background. If active
RhoA is required for Rac1 function, we would expect a
Rac1V12 phenotype of the double transfectant. The re-
sults showed that the cellular phenotype of double trans-
fectants was that of RhoAV14 cells. The simplest explana-
tion of our results is that RhoA-induced changes in
cellular organization dominate changes induced by Rac1,
including the displacement of Rac1 from binding sites at
cell–cell contacts. At present, we do not understand the
mechanism(s) involved. That RhoA displaces Rac1 di-
rectly seems unlikely since the distributions of these pro-
teins are grossly different. Alternatively, RhoA may in-
duce a change in cellular structure/organization that
effects Rac1 activity/distribution resulting in displacement
of Rac1 (see below).
RhoA and Rac1 Regulate the Organization of Distinct 
Actin Cytoskeletons Associated with Basal, Lateral, and 
Apical Membrane Domains
Targets of RhoA and Rac1 activity in fibroblasts are asso-
ciated with actin membrane structures characteristic of
single, motile cells, including stress fibers and focal adhe-
sions (RhoA), and lamellipodia and membrane ruffles
(Rac1) (Burridge et al., 1997; Hall, 1998). Note that at low
cell densities, the effects of RhoA and Rac1 mutants on
MDCK cells were similar to those induced in fibroblasts
(Ridley and Hall, 1992; Ridley et al., 1992), including in-
creased formation of stress fibers and cell spreading
(RhoA), and increased lamellipodia and ruffled edges
(Rac1). These results indicate that the targets of RhoA
and Rac1 in fibroblasts and epithelial cells may be similar
when epithelial cells are single, motile, and nonpolarized.
In contrast to fibroblasts, however, polarized epithelial
cells assemble different types of actin structures in associa-
tion with structurally and functionally distinct basal, lat-
eral, and apical plasma membrane domains. These actin
structures are (a) stress fibers at the basal surface next to
the substratum (Burridge et al., 1997), (b) a circumferen-
tial organization of actin filaments at lateral membranes in
association with cell–cell junctional complexes (Takeichi,
1991), and (c) actin bundles and a terminal web associated
with microvilli at the apical membrane (Mooseker, 1985).
Changes in actin organizations in polarized cells and the
ensuing effects of cellular organization were dependent on
which RhoA or Rac1 mutant was expressed.
F-actin staining was significantly more intense and had
an unusual beaded organization (rather than the continu-
ous line in control cells) at cell–cell contacts of both
Rac1V12 and Rac1N17 cells. Takaishi et al. (1997) re-
ported that F-actin staining was weaker at cell–cell con-
tacts of MDCK cells expressing Rac1N17, but strong in
Rac1V12 cells as we showed here. The different Rac1N17
result might be due to the wide difference in levels of ex-
pression between the studies. In our study, expression lev-
els of Rac1V12 and Rac1N17 were equal to or higher than
endogenous Rac1 by Western blotting of whole cell ex-
tracts, whereas they were not detectable in the study by
Takaishi et al. (1997). We do not know why the distribu-
tion of F-actin was more beaded than linear. It is possible
that this organization reflected an increase in recruitment
and assembly of F-actin at those sites, and/or changes in
lateral membrane structure such as increased interdigita-
tions (Takaishi et al., 1997). The actin organization was
also different at the apical membrane domain of both
Rac1V12 and Rac1N17 cells compared with controls. In
general, we detected weaker staining of F-actin in stress fi-
bers in cells expressing Rac1V12 or Rac1N17 than in con-
trols. In RhoAV14 and RhoAN19 cells, F-actin was prom-
inently localized in stress fibers at the base of cells and in a
broad cortical belt at lateral membranes that contrasted
with the finely beaded distribution in cells expressing Rac1
mutants. In general, the RhoAV14 and RhoAN19 cells
spread flatter on the substratum and became more fibro-
blastic in morphology, but cell–cell contacts were main-
tained.
As epithelial cells transform from single, motile cells to
a static monolayer of polarized cells, the organization of
actin changes from one that functions in cell–substratum
adhesion and motility to one that also maintains cell–cell
adhesion and protein distributions at lateral and apical
membrane domains. RhoA may regulate actin structures
that determine cell–substratum contact and motility in sin-
gle cells, as in fibroblasts (Ridley and Hall, 1992; Ridley et al.,
1992), whereas Rac1, and possibly RhoA, may regulate ac-
tin structures associated with cell–cell contacts and spe-
cialization of the apical membrane in cell monolayers.
Note that in double transfectants, the fibroblastic pheno-
type of RhoA mutants dominated the Rac1 phenotype, in-
dicating that the ground state for these cells may be a
motile, fibroblastic morphology and that combinatorial
effects of RhoA and Rac1 help to drive these cells towards
an epithelial phenotype. We do not know how changes in
actin organizations between cell–substratum contacts, cell–
cell contacts, and the apical membrane might be orches-
trated by Rac1 or RhoA. We also do not know if addition
of actin to one structure (e.g., cell–cell contacts) is made at
the expense of actin in another structure (e.g., cell–sub-The Journal of Cell Biology, Volume 142, 1998 98
stratum contacts). In this context, it is interesting to note
that Friederich et al. (1989) showed that expression of vil-
lin induced growth of actin-containing microvilli from the
free surface of fibroblasts and, concomitantly, a decrease
in the density of stress fibers at the base of the cell.
Recent studies have identified some targets for RhoA
GTPases that precipitate changes in the actin cytoskele-
ton. Rho-kinase is a potentially important target as its ac-
tivity affects many regulators of the actin cytoskeleton, in-
cluding myosin II, ERM proteins (Burridge et al., 1997),
and adducin (Kimura et al., 1998). Another target may be
phosphatidylinositol 4-phosphate 5-kinase (Chong et al.,
1994), which regulates PIP2 synthesis. PIP2 has broad ef-
fects on the actin cytoskeleton by binding to actin-mono-
mer binding proteins (e.g., profilin), which results in re-
lease of actin monomers (Lassing and Lindberg, 1985;
Goldschmidt et al., 1990). As these targets were identified
in single, motile cells, it is possible that they are important
at least in actin organization at cell–substratum contacts in
single nonpolarized cells and in polarized epithelial cells.
Whether they are important in actin organizations at cell–
cell contacts or actin membrane specializations in these
cells will need further study. We note, however, that the
ERM family (radixin, Matsui et al., 1998; ezrin, Chen et
al., 1995; Yao and Forte, 1996) and adducin (Kaiser et al.,
1989) have been implicated in the organization of cell–cell
adhesion and the actin cytoskeleton.
Different Effects of RhoA and Rac1 Mutants 
on the Distribution of Apical and Basal–Lateral 
Membrane Proteins
We showed that changes in F-actin induced by expression
of RhoA or Rac1 mutants also correlated with compensa-
tory changes in the distribution and organization of two
actin-associated proteins, E-cadherin and GP135. Interest-
ingly, the effects of Rac1 mutants depended on the stage
of development of cell polarity. At low density, when cells
had just initiated cell–cell contacts, Rac1V12 and E-cad-
herin colocalized at cell–cell contacts in a linear staining
pattern similar to that of E-cadherin in controls. Braga et
al. (1997) observed a similar increase in cadherin staining
during formation of cell–cell contacts in keratinocytes. Al-
though Rac1N17 and E-cadherin also colocalized at cell–
cell contacts, we found both proteins in large aggregates
that were not associated with cell–cell contacts. Similar ob-
servations were not reported by Takaishi et al. (1997), but
they did not examine low-density cultures. We have pre-
liminary evidence that E-cadherin is recruited from intra-
cellular stores to cell–cell contacts during initial stages of
cell–cell adhesion (Siemers, K., and W.J. Nelson, unpub-
lished results), and it is possible that Rac1N17 somehow
inhibits the release of E-cadherin from these stores, per-
haps by affecting linkage of E-cadherin and the actin cy-
toskeleton, which is critical for the maturation of cell–cell
contacts (Adams, C., Y.-T. Chen, S. J Smith, and W.J. Nel-
son, manuscript submitted for publication). Nevertheless,
the sequestration of E-cadherin in membranes not at cell–
cell contacts would decrease the amount of E-cadherin
available for cell–cell adhesion. Braga et al. (1997) re-
ported that microinjection of Rac1N17 into keratinocytes
during induction of cell–cell adhesion caused cadherin to
disappear from cell–cell contacts, although it was not clear
if E-cadherin was degraded or redistributed. However, our
study, and that of Takaishi et al. (1997) demonstrated that
steady-state amounts of E-cadherin and catenins in cells
expressing RhoA or Rac1 mutants were similar to those in
controls, indicating that changes in E-cadherin organiza-
tion were likely due to protein redistribution rather than
degradation.
In polarized cell monolayers at confluent cell density,
we observed that in Rac1V12 cells, E-cadherin and F-actin
had a finely beaded organization at cell–cell contacts that
appeared denser than in controls. This confirms results of
recent studies of Rac1V12 expression in MDCK cells (Ta-
kaishi et al., 1997) and Rac1L61 expression in kerati-
nocytes (Braga et al., 1997). However in contrast to those
studies, we found that E-cadherin and F-actin were still lo-
calized to cell–cell contacts in the presence of Rac1N17.
Takaishi et al. (1997) reported decreased staining intensity
of E-cadherin/catenins at MDCK cell–cell contacts, al-
though protein levels were the same as in the control, and
Braga et al. (1997) reported loss of E-cadherin from kerat-
inocyte cell–cell contacts when Rac1N17 was microin-
jected 3 h after induction of cell–cell adhesion. We note
that levels of Rac1N17 expression in our studies were
more than sixfold higher than the endogenous Rac1 level,
whereas in studies by Takaishi et al. (1997) the amount of
Rac1N17 expressed was too low to be detected in Western
blots of whole cell lysates. In the study by Braga et al.
(1997), effects of Rac1N17 were reported in cells that had
just formed cell–cell contacts, with results similar to those
reported here (see above), but were not reported in estab-
lished cell monolayers. That Rac1N17 had a different ef-
fect on E-cadherin/actin organization in confluent MDCK
cell monolayers is also indicated by the observation that
intracellular aggregates containing Rac1N17, E-cadherin,
and F-actin, which were prominent in small colonies of
cells, were not found in polarized cell monolayers. It is
possible that long-term cell–cell contacts are more refrac-
tory to the effects of Rac1N17, perhaps as a result of the
reorganization of actin after the establishment of cell–cell
contacts (see above).
We also examined the distribution of an apical mem-
brane protein, GP135, in cells expressing different RhoA
or Rac1 mutants. We found that expression of RhoA and
Rac1 mutants had little effect on GP135 organization at
low cell densities. However, in confluent monolayers
GP135 distribution was disrupted in cells expressing Rac1
or RhoA mutants: in Rac1V12 cells, GP135 was tightly
clumped beneath the apical membrane; in Rac1N17 cells,
the distribution of GP135 was similar to the control, but
the fine, granular staining appeared to be excluded from
the center of the apical membrane; in RhoAV14 cells,
GP135 was almost absent from the apical membrane and
was instead localized in the lateral membrane and intracel-
lular structures (Fig. 7).
With the exception of Rac1N17 cells, in which the defect
in GP135 organization was mild, abnormalities in GP135
and F-actin organizations at the apical membrane coin-
cided in Rac1V12 and RhoAV14 cells. The organization of
actin at the apical membrane is structurally complex and
very different from that at other membrane domains. A
bundle of actin filaments is attached to the tip of each mi-Jou and Nelson RhoA Functions in Epithelial Polarity 99
crovillus and inserts into the terminal web of actin fila-
ments and associated proteins located beneath the apical
membrane (Mooseker, 1985). The fine, granular staining
pattern of GP135 in control cells reflects the organization
of short microvilli on the apical surface, and disruptions in
this pattern may, therefore, reflect changes in microvillar
actin organization. The location of the intracellular aggre-
gate of GP135 and F-actin in Rac1V12 cells is reminiscent
of the apical recycling compartment or endosome that has
been described previously (Apodaca et al., 1994;Odorizzi
et al., 1996). This recycling endosomal compartment re-
ceives transcytotic vesicles from the basal–lateral mem-
brane and endocytic vesicles internalized from the apical
membrane, and it sends out vesicles to the apical mem-
brane. It is possible that Rac1V12 inhibited either GP135
delivery from the Golgi to the apical membrane or the re-
cycling of internalized GP135 back to the apical mem-
brane, or that it increased the rate of internalization of
GP135 from the apical membrane. Note that we also
showed that the vesicular aggregate containing GP135 and
Rac1V12 colocalized with rab11 (Fig. 8), which may be in-
volved in regulating vesicle traffic to or from endosomal
compartments (Lazar et al., 1997; Novick and Zerial,
1997). Although it is not known if Rac1 plays a role in di-
rect vesicle transport from the Golgi to the plasma mem-
brane, it has been shown to affect endocytosis (Lamaze
et al., 1996), which, at the apical membrane in MDCK
cells, is actin dependent (Gottlieb et al., 1993). The appar-
ent mislocalization of GP135 to lateral membranes in
RhoAV14 cells (Fig. 7 B) may reflect mistargeting of
GP135 from the Golgi or loss of the tight junction fence to
GP135 diffusion from the apical to the lateral membrane.
However, results reported in the accompanying study (Jou
et al., 1998) indicate that the latter possibility is unlikely.
Further studies will be required to identify the defect in
GP135 trafficking in these cells.
In summary, our analysis indicates that RhoA and Rac1
play important roles in the transition of epithelial cells
from a motile, fibroblastic morphology to a static, polar-
ized epithelium. This transition coincides with changes in
the organization of the actin cytoskeleton. RhoA appears
to regulate actin stress fibers at the basal membrane that
are characteristic of single, motile cells. As RhoA mutants
dominate (subsequent) Rac1 effects, RhoA-controlled fi-
broblastic structures may represent a ground state from
which epithelial structures are built. Initiation of cell–cell
contact leads to the formation of new actin structures and
the specialization of lateral and apical membranes. Al-
though RhoA may play an additional role during this reor-
ganization (Jou et al., 1998), Rac1 activity appears to be
required to assemble circumferential actin structures at
the lateral membrane and actin structures associated with
microvilli at the apical membrane, which affect the distri-
butions of actin-associated membrane proteins.
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